Denali Therapeutics, Inc. (DNLI)

20.57 -0.14 (-0.68%) USD  |  NASDAQ  |  Apr 17, 16:00
20.56 -0.02 (-0.07%) Pre-Market: 20:00
More

Denali Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Neurocrine Biosciences, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Biogen, Inc. Upgrade
Agenus, Inc. Upgrade
Curis, Inc. Upgrade